These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32044690)

  • 1. Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia.
    Varghese L; Ezat Wan Puteh S; Schecroun N; Jahis R; Van Vlaenderen I; Standaert BA
    Value Health Reg Issues; 2020 May; 21():172-180. PubMed ID: 32044690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gains.
    Standaert B; Schecroun N; Ethgen O; Topachevskyi O; Morioka Y; Van Vlaenderen I
    Health Policy; 2017 Dec; 121(12):1303-1312. PubMed ID: 29079394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing dengue fever cases at the lowest budget: a constrained optimization approach applied to Thailand.
    Knerer G; Currie CSM; Brailsford SC
    BMC Public Health; 2021 Apr; 21(1):807. PubMed ID: 33906628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong.
    Wu DB; Roberts C; Lee VW; Hong LW; Tan KK; Mak V; Lee KK
    Hum Vaccin Immunother; 2016; 12(2):403-16. PubMed ID: 26451658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B
    Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
    Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
    Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.
    Delgleize E; Leeuwenkamp O; Theodorou E; Van de Velde N
    BMJ Open; 2016 Nov; 6(11):e010776. PubMed ID: 27903558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project.
    Standaert B; Van Vlaenderen I; Van Bellinghen LA; Talbird S; Hicks K; Carrico J; Buck PO
    Appl Health Econ Health Policy; 2020 Aug; 18(4):519-531. PubMed ID: 31755016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review.
    Straetemans M; Buchholz U; Reiter S; Haas W; Krause G
    BMC Public Health; 2007 Sep; 7():236. PubMed ID: 17825095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
    Pooripussarakul S; Riewpaiboon A; Bishai D; Muangchana C; Tantivess S
    BMC Public Health; 2016 Aug; 16():684. PubMed ID: 27484123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.
    Chhatwal J; Kanwal F; Roberts MS; Dunn MA
    Ann Intern Med; 2015 Mar; 162(6):397-406. PubMed ID: 25775312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain.
    Imaz I; Rubio B; Cornejo AM; González-Enríquez J
    Prev Med; 2014 Apr; 61():116-21. PubMed ID: 24360847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
    Chen C; Beutels P; Wood J; Menzies R; MacIntyre CR; McIntyre P; Newall AT
    Vaccine; 2018 Oct; 36(42):6307-6313. PubMed ID: 30213457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.
    Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K
    Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Fidelity Rollout Algorithm for Dynamic Resource Allocation in Population Disease Management.
    Ho TY; Liu S; Zabinsky ZB
    Health Care Manag Sci; 2019 Dec; 22(4):727-755. PubMed ID: 30194509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy.
    Castiglia P; Pradelli L; Castagna S; Freguglia V; Palù G; Esposito S
    Hum Vaccin Immunother; 2017 Oct; 13(10):2307-2315. PubMed ID: 28700264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling.
    Shafie AA; Yeo HY; Coudeville L; Steinberg L; Gill BS; Jahis R; Amar-Singh Hss
    Pharmacoeconomics; 2017 May; 35(5):575-589. PubMed ID: 28205150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan.
    Hoshi SL; Kondo M; Okubo I
    PLoS One; 2015; 10(10):e0139140. PubMed ID: 26444287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.